Literature DB >> 15292327

Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis.

Amalia Gastaldelli1, Yoshinori Miyazaki, Maura Pettiti, Emma Buzzigoli, Srikanth Mahankali, Ele Ferrannini, Ralph A DeFronzo.   

Abstract

The contribution of increased gluconeogenesis (GNG) to the excessive rate of endogenous glucose production (EGP) in type 2 diabetes (T2DM) is well established. However, the separate effects of obesity (total body fat), visceral adiposity, and T2DM have not been investigated. We measured GNG (by the (2)H(2)O technique) and EGP (with 3-(3)H-glucose) after an overnight fast in 44 type 2 diabetic and 29 gender/ethnic-matched controls. Subjects were classified as obese (body mass index 30 kg/m(2) or greater) or nonobese (body mass index < 30 kg/m(2)); diabetic subjects were further subdivided according to the severity of fasting hyperglycemia [fasting plasma glucose (FPG) < 9 mm or >or= 9 mm]. EGP was similar in nondiabetic controls and T2DM with FPG less than 9 mm but was increased in T2DM with FPG >or= 9 mm (P < 0.001). Within the diabetic groups, obesity had an independent effect to further increase basal EGP (P < 0.01). In both nonobese diabetic groups, both the percent GNG and gluconeogenic flux were increased, compared with nonobese nondiabetic controls. In both diabetic groups, obesity further increased both percent GNG and gluconeogenic flux. In obese and nonobese T2DM, the increase in gluconeogenic flux was not accompanied by a reciprocal decrease in glycogenolysis, indicating a loss of hepatic autoregulation. By multivariate analysis, gluconeogenic flux was positively correlated with percent body fat, visceral fat, and the fasting plasma free fatty acid and glucose concentrations (all P <or= 0.02). We conclude that obesity per se, and visceral fat accumulation in particular, as well as poorly controlled diabetes are potent stimuli to augment gluconeogenic flux.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292327     DOI: 10.1210/jc.2003-031941

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  29 in total

Review 1.  A Comprehensive Review of Novel Drug-Disease Models in Diabetes Drug Development.

Authors:  Puneet Gaitonde; Parag Garhyan; Catharina Link; Jenny Y Chien; Mirjam N Trame; Stephan Schmidt
Journal:  Clin Pharmacokinet       Date:  2016-07       Impact factor: 6.447

2.  Strength exercise improves muscle mass and hepatic insulin sensitivity in obese youth.

Authors:  Gert-Jan Van Der Heijden; Zhiyue J Wang; Zili Chu; Gianna Toffolo; Erica Manesso; Pieter J J Sauer; Agneta L Sunehag
Journal:  Med Sci Sports Exerc       Date:  2010-11       Impact factor: 5.411

Review 3.  The mitochondrial isoform of phosphoenolpyruvate carboxykinase (PEPCK-M) and glucose homeostasis: has it been overlooked?

Authors:  Romana Stark; Richard G Kibbey
Journal:  Biochim Biophys Acta       Date:  2013-10-28

Review 4.  Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms.

Authors:  Chiara Saponaro; Melania Gaggini; Amalia Gastaldelli
Journal:  Curr Diab Rep       Date:  2015-06       Impact factor: 4.810

5.  Long non-coding RNA H19 inhibition promotes hyperglycemia in mice by upregulating hepatic FoxO1 levels and promoting gluconeogenesis.

Authors:  Neha Goyal; Shweta Tiwary; Devesh Kesharwani; Malabika Datta
Journal:  J Mol Med (Berl)       Date:  2018-11-21       Impact factor: 4.599

6.  Paradigm Shifts in Nocturnal Glucose Control in Type 2 Diabetes.

Authors:  Ananda Basu; Nisha Joshi; John Miles; Rickey E Carter; Robert A Rizza; Rita Basu
Journal:  J Clin Endocrinol Metab       Date:  2018-10-01       Impact factor: 5.958

7.  Increased gluconeogenesis in youth with newly diagnosed type 2 diabetes.

Authors:  Stephanie T Chung; Daniel S Hsia; Shaji K Chacko; Luisa M Rodriguez; Morey W Haymond
Journal:  Diabetologia       Date:  2014-12-03       Impact factor: 10.122

8.  Weight loss reduces liver fat and improves hepatic and skeletal muscle insulin sensitivity in obese adolescents.

Authors:  Bernadette E Vitola; Sheela Deivanayagam; Richard I Stein; Balsamanirina S Mohammed; Faidon Magkos; Erik P Kirk; Samuel Klein
Journal:  Obesity (Silver Spring)       Date:  2009-06-04       Impact factor: 5.002

9.  Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents.

Authors:  Sheela Deivanayagam; B Selma Mohammed; Bernadette E Vitola; Gihan H Naguib; Tamir H Keshen; Erik P Kirk; Samuel Klein
Journal:  Am J Clin Nutr       Date:  2008-08       Impact factor: 7.045

10.  Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction.

Authors:  Erik Kirk; Dominic N Reeds; Brian N Finck; S Mitra Mayurranjan; Mitra S Mayurranjan; Bruce W Patterson; Samuel Klein
Journal:  Gastroenterology       Date:  2009-01-25       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.